Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.

Título traducido de la contribución: Despigmentación bilateral del iris e hipotonía ocular como manifestaciones en fase terminal de la enfermedad de Vogt-Koyanagi-Harada no tratada.

Miguel Cuevas, Alejandra de-la-Torre, Andrea Córdoba

Resultado de la investigación: Contribución a RevistaArtículo

Resumen

PROPÓSITO:
Describir la despigmentación bilateral grave del iris y la hipotonía ocular persistente como manifestaciones terminales de la enfermedad de Vogt-Koyanagi-Harada no tratada.

MÉTODOS:
Se presentan los hallazgos clínicos y los estudios diagnósticos realizados en tres pacientes con despigmentación bilateral del iris.

RESULTADOS:
La enfermedad de Vogt-Koyanagi-Harada en estadio recurrente tardío fue diagnosticada en tres pacientes con despigmentación grave bilateral del iris e hipotonía ocular persistente.

CONCLUSIONES:
El diagnóstico y tratamiento precoz de la inflamación son factores cruciales en el resultado clínico de la enfermedad de Vogt-Koyanagi-Harada. Cuando se deja sin diagnosticar y sin tratar desde las primeras etapas, se puede desarrollar una severa despigmentación del iris e hipotonía ocular, manifestaciones poco comunes de esta enfermedad.

Traducción realizada con el traductor www.DeepL.com/Translator
Idioma originalEnglish (US)
Número de artículoPMID: 28548582
Páginas (desde-hasta)1-6
Número de páginas6
PublicaciónOcular Immunology and Inflammation
Fecha en línea anticipadamar 26 2017
DOI
EstadoPublished - may 26 2017

Huella dactilar

Ocular Hypotension
Uveomeningoencephalitic Syndrome
Iris
Early Diagnosis
Inflammation

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Ophthalmology

Concepts

  • Concepto

Citar esto

@article{cc472211d05347908b1c6b710f87fb2c,
title = "Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.",
abstract = "Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop.",
author = "Miguel Cuevas and Alejandra de-la-Torre and Andrea C{\'o}rdoba",
year = "2017",
month = "5",
day = "26",
doi = "10.1080/09273948.2017.1320411",
language = "English (US)",
pages = "1--6",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",

}

Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease. / Cuevas, Miguel; de-la-Torre, Alejandra; Córdoba, Andrea.

En: Ocular Immunology and Inflammation, 26.05.2017, p. 1-6.

Resultado de la investigación: Contribución a RevistaArtículo

TY - JOUR

T1 - Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.

AU - Cuevas, Miguel

AU - de-la-Torre, Alejandra

AU - Córdoba, Andrea

PY - 2017/5/26

Y1 - 2017/5/26

N2 - Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop.

AB - Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop.

U2 - 10.1080/09273948.2017.1320411

DO - 10.1080/09273948.2017.1320411

M3 - Article

C2 - 28548582

AN - SCOPUS:85019707641

SP - 1

EP - 6

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

M1 - PMID: 28548582

ER -